AptarGroup's packaging to protect COVID-19 tests
CRYSTAL LAKE -- AptarGroup Inc. said its Activ-Film technology was selected to protect a new SARS Rapid Antigen test for COVID-19 that recently received approval from the U.S. Food and Drug Administration.
The QuickVue SARS Antigen test was developed by Quidel Corp. and delivers test results in 10 minutes. Activ-Film technology is integrated into the diagnostic kit to protect against moisture and other environmental conditions that could otherwise impact test accuracy.
"We are pleased to partner with Quidel Corp. on this critical diagnostic tool and help bring the QuickVue SARS Antigen test to the market," said Stephan B. Tanda, Aptar president and CEO.
Aptar designs and manufactures a broad range of drug delivery, consumer product dispensing and active material solutions. Aptar's solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage.